Cargando…
SEOM clinical guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2018)
The goal of this article is to provide recommendations about the management of muscle-invasive (MIBC) and metastatic bladder cancer. New molecular subtypes of MIBC are associated with specific clinical–pathological characteristics. Radical cystectomy and lymph node dissection are the gold standard f...
Autores principales: | González del Alba, A., De Velasco, G., Lainez, N., Maroto, P., Morales-Barrera, R., Muñoz-Langa, J., Pérez-Valderrama, B., Basterretxea, L., Caballero, C., Vazquez, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339669/ https://www.ncbi.nlm.nih.gov/pubmed/30565086 http://dx.doi.org/10.1007/s12094-018-02001-x |
Ejemplares similares
-
SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016)
por: Lázaro, M., et al.
Publicado: (2016) -
SEOM-SOGUG clinical guideline for localized muscle invasive and advanced bladder cancer (2021)
por: Valderrama, Begoña P., et al.
Publicado: (2022) -
SEOM clinical guidelines in metastatic breast cancer 2015
por: Gavilá, J., et al.
Publicado: (2015) -
SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer (2018)
por: Gómez-España, M. A., et al.
Publicado: (2018) -
SEOM SOGUG clinical guideline for treatment of kidney cancer (2022)
por: Méndez-Vidal, María José, et al.
Publicado: (2023)